Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Protocol Evaluating Return of Actionable Genetic Research Results to Biobank Participants

NCT04242667 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT04242667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04242667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Protocol Evaluating Return of Actionable Genetic Research Results to Biobank Participants
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2020
Completion date
August 1, 2023
Enrollment
260 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cardiovascular diseases, hereditary cancer, hereditary cardiac amyloidosis